EUVIMEDEUVIMED entdecken
Metaanalyse

Association Between Systemic Immune-Inflammation Index and Adverse Outcomes in Patients With Acute Coronary Syndrome: A Meta-Analysis

Shengpeng Wang, Guannan Zhang iD

Angiology · 2025-11 · 76 (10) · 946-954

DOI: 10.1177/00033197241263399 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Angiology, online erschienen am 21.06.2024. Verfasst von Shengpeng Wang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Medicine Class 2020, Medical College of Jinzhou Medical University, Jinzhou, China. Hauptthemen laut MEDLINE: Acute Coronary Syndrome, Inflammation. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The systemic immune-inflammation index (SII) has been developed for the risk prognostication of acute coronary syndrome (ACS) patients. This meta-analysis aimed to assess the value of SII for predicting adverse outcomes in ACS patients. Relevant studies were identified by searching the PubMed, Web of Science, and Embase databases. Studies that investigated the association of SII with all-cause mortality or major adverse cardiovascular events (MACEs) in ACS patients were eligible. The short-term outcomes were defined as adverse events occurring during the hospital and within 30 days. 11 studies with 16,596 patients were eligible for analysis. A random effect meta-analysis indicated that a higher SII level significantly predicted short-term death (hazard ratios [HR] 2.60; 95% confidence intervals [CI] 1.29–5.25) and long-term all-cause mortality (HR 2.40; 95% CI 1.25–4.59), even after adjusting for traditional confounding factors. Additionally, a higher SII level was also significantly associated with an increased risk of short-term MACEs (HR 1.61; 95% CI 1.28–2.03) and long-term MACEs (HR 2.43; 95% CI 1.74–3.40). These findings suggest that SII level has a strong prognostic value for both MACEs and all-cause mortality in patients with ACS. Determining the SII level has the potential to improve risk prognostication in ACS patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Coronary SyndromeInflammationFemaleHumansMalePrognosisRisk AssessmentRisk Factors

Stichwörter der Autor:innen

acute coronary syndromeall-cause mortalitymajor adverse cardiovascular eventsmeta-analysissystemic immune-inflammation index

Autor:innen und Institutionen

  • Clinical Medicine Class 2020, Medical College of Jinzhou Medical University, Jinzhou, China.
  • Department of Cardiology, The Third Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.

ORCID-Profile: Guannan Zhang

Zitieren

APA

Wang, S., & Zhang, G. (2025). Association Between Systemic Immune-Inflammation Index and Adverse Outcomes in Patients With Acute Coronary Syndrome: A Meta-Analysis. Angiology, 76(10), 946-954. https://doi.org/10.1177/00033197241263399

Vancouver

Wang S, Zhang G. Association Between Systemic Immune-Inflammation Index and Adverse Outcomes in Patients With Acute Coronary Syndrome: A Meta-Analysis. Angiology. 2025;76(10):946-954. doi:10.1177/00033197241263399

BibTeX
@article{Wang2025,
  author = {Wang, Shengpeng and Zhang, Guannan},
  title = {Association Between Systemic Immune-Inflammation Index and Adverse Outcomes in Patients With Acute Coronary Syndrome: A Meta-Analysis},
  journal = {Angiology},
  year = {2025},
  volume = {76},
  number = {10},
  pages = {946--954},
  doi = {10.1177/00033197241263399}
}
Kostenlos starten →